Insulin aspart, recombinant Subcutaneous and Tafluprost ophthalmic
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Tafluprost ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: tafluprost ophthalmic
Brand name: Zioptan
Synonyms: Tafluprost
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Tagamet
- Insulin aspart, recombinant Subcutaneous-Tagamet HB
- Insulin aspart, recombinant Subcutaneous-Tagraxofusp
- Insulin aspart, recombinant Subcutaneous-Tagraxofusp-erzs
- Insulin aspart, recombinant Subcutaneous-Tagrisso
- Insulin aspart, recombinant Subcutaneous-Take Action
- Tafluprost ophthalmic-Insulin degludec
- Tafluprost ophthalmic-Insulin Degludec (U-100) Prefilled Pens
- Tafluprost ophthalmic-Insulin Degludec (U-100) Vials
- Tafluprost ophthalmic-Insulin Degludec (U-200) Prefilled Pens
- Tafluprost ophthalmic-Insulin degludec and liraglutide
- Tafluprost ophthalmic-Insulin degludec and liraglutide Subcutaneous